Daclizumab Subcutaneous and Eliquis

• Generic Name: daclizumab
• Dosage Forms: n.a.
• Other Brand Names: Zinbryta, Zenapax

Daclizumab injection is used to treat the relapsing forms of multiple sclerosis (MS). Daclizumab will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used when other medicines to treat MS did not work well.

Daclizumab was available only under a restricted distribution program called the Zinbryta® REMS (Risk Evaluation and Mitigation Strategy) Program.

Daclizumab was voluntarily withdrawn from the worldwide market on March 2, 2018 due to safety concerns.

• Generic Name: apixaban
• Dosage Forms: tablet, film coated
• Other Brand Names: Eliquis, Eliquis Starter Pack for Treatment of DVT and PE

Eliquis (apixaban) blocks the activity of certain clotting substances in the blood.

Eliquis is used to lower the risk of stroke or a blood clot in people with a heart rhythm disorder called atrial fibrillation.

Eliquis is also used to lower the risk of forming a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery.

Eliquis is used to treat blood clots in the veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism), and lower the risk of them occurring again.